Key Points
- Bill 8333 transposes Directive (EU) 2022/2100 into Luxembourg law.
- Bans flavourings for heated tobacco; requires health warnings and packaging rules.
- Nicotine pouches regulated: ad bans, youth sales ban, 0.048 mg nicotine cap.
- CBD and caffeine additives prohibited.
- Vending machines must show warnings; no promotional graphics.
2Firsts, October 31, 2025 — Luxembourg has passed Bill No. 8333 on tobacco control, marking a significant reform of its public health policy. The legislation transposes EU Directive (EU) 2022/2100 and expands national restrictions to heated tobacco, e-cigarettes, and nicotine pouches.
Under the law, flavourings for heated tobacco are banned, and packaging must carry health warnings. Cigarette packs may only be sold in multiples of five, and vending machines must display health warnings and remove promotional graphics.
For the first time, nicotine pouches fall under tobacco regulations:
- Advertising and sales to minors are banned;
- Packaging and labelling requirements apply;
- Nicotine content capped at 0.048 mg per pouch/gram;
- Additives such as CBD and caffeine are prohibited;
- Use is restricted in public spaces frequented by youth.
Health organisations including the Cancer Foundation, Medical College, and Children’s Ombudsman (OKAJU) welcomed the move as necessary, though the Medical College urged clearer separation between consumer and cessation products.
The Chamber of Commerce, however, criticised the law as “gold-plating” EU rules, arguing that strict limits on nicotine amount to a de facto ban and could spur black markets and cross-border sales. Businesses also faulted the government for providing no adequate transition period.
The Council of State lifted its last reservations in July 2025, allowing the bill’s adoption without a second constitutional vote. The law takes effect on the first day of the month after publication in the Journal Officiel, with vending display rules applying after a three-month grace period.
Image source: Delano
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
